Inactief instrument

Officiële publicaties THERACLION N Euronext Paris

Aandelen

slotkoers Euronext Paris Andere beurzen
- ^EUR	-

27/03	Theraclion SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Theraclion bereikt een belangrijke mijlpaal op weg naar de Amerikaanse markt: Eerste patiënten behandeld met Sonovein als onderdeel van de door de FDA goedgekeurde pivotale studie	CI

Combined general shareholders meeting	13/05	CO
Financial report	25/04	CO
Annual results	27/03	CO
Annual results	27/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	01/02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	30/01	CO
4th quarter turnover	29/01	CO
4th quarter turnover	29/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	31-10-23	CO
Half-year report	30-10-23	CO
1st-half-year results	11-10-23	CO
1st-half-year results	11-10-23	CO
Monthly statement on voting rights	30-09-23	CO
Monthly statement on voting rights	31-08-23	CO
Monthly statement on voting rights	31-07-23	CO
Minutes of the general assembly	29-06-23	CO
Admission of new securities	22-06-23	CO
Admission of new securities	22-06-23	CO
Mixed general Shareholders meeting notice	14-06-23	CO
Monthly statement on voting rights	31-05-23	CO
Changes in management and corporate officers	25-05-23	CO
Changes in management and corporate officers	25-05-23	CO
Combined general shareholders meeting	24-05-23	CO